Alsayed Hasan, Marah http://orcid.org/0000-0003-4182-536X
Schwartz, Stanley
McKenna, Victoria
Ing, Richard
Article History
Received: 15 August 2022
Revised: 18 July 2023
Accepted: 25 July 2023
First Online: 2 August 2023
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent was obtained from all individual participants included in the study.
: Stanley Schwartz is the advisor of Lilly Pharmaceuticals from 2022 to present. All the other authors declare no competing interests.